Here we go again...$60 support is back againMultiple bottom and very strong support @ $60. We might go slighty below on earnings ($52-55), so I would set SL below $50. Buy $55-60, TP $85-120.
GILD trade ideas
GILD to LongIn Monthly Demand Zone
Entry 60.5
Stop: 59
Target: 68; reward:risk=4:1
Earning date 10/28/2020 4PM
I am not a PRO trader. I need few months to practice trading strategies.
If you like this idea, please use SIM/Demo account to try it, until my trading plans get high winning rate.
GILD short term Earnings PlayWe’ve seen this before on Gilead pre-pandemic;
It traded sideways above this zone for a little over a year on descending YOY earnings since 2016. Following the gap down 19 AUG, we’re now seeing a bullish MACD divergence plus an ascending RSI on the daily to signal a break of the recent down trend. With more positive news surrounding their COVID-19 treatment drug, Remdesivir, would love to see a short term build up before ER to the 67-70 zone.
ER date has not been announced but is estimated to be on 10/22.
GILEAD SCIENCES buy signals.GILEAD SCIENCES, D1: Support zone + 4X Divergence + Nice discount + Breakout of resistance line
Time to buy GILD. Dropped too far. RemesvidirTime to buy GILD. Remesvidir and recently bounced off a low resistance of approximately $61.
Remesvidir recently was said to reduce recovery time from Covid-19. More info: www.gilead.com
GILD Neutral, Sell put below sidewaysBreakaway Gap. Down trendline break
Sideways 62 - 67
Stock trade:
Entry 64
Stop 61.5
Target 72; reward:risk=3:1
Option trade: Sell put below the support price
Close this position before 10/22/2020 Earning.
I am not a PRO trader. I need few months to practice trading strategies.
If you like this idea, please use SIM/Demo account to try it, until my trading plans get high winning rate.
Long Gild - Covid Drug ($MRNA $GSK $INO $SPY $PFE $JNJ $MRK)see full chart at www.tradingview.com
Gild
Entry $62 area
Target 1 $67
Target 2 $71
stoploss $59
Why this play?
Trump used Gild's drug as part of his treatment, if he pulls thru with a full recovery. they will probably start pumping the news about this company and it'll finally have enough momentum to move back to the upside.
What is Gild?
Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Notable price upgrades
Sep-30-20 Resumed Jefferies Buy $78
Sep-15-20 Upgrade Maxim Group Hold → Buy $88
GILD Watch for Breakout here! TRUMP PUMP! Gild on high watch with Trump receiving REMDISIVIR treatment and Trump reporting he is feeling better and expected to be discharged and return soon. Which means we could see green market this week. GILD is at my support zone and we have a gap up to fill at $69 If we can hold above $61.62 we could see a move back up to fill that gap. Good opportunity to long here!
Gilead Sciences Stock AnalysisBased on Technical Analysis the best option is to hold and wait the end of the price retracement before going long.
Trump has been treated with Gilead Sciences remdesivir.
$GILD - Needs to stabilize above 63.13Potential Long entry above 63.2 (Closing price)
Not for any advise
Just an Idea,
$GILD trend reversal ? it maybe a trend reversal for $GILD
the stock has good fundamentals ,, and the company was providing COVID-19 medicine for free ,, now they put a price for each patient treatment course nearly 2000$
so it maybe will push the company earnings .
it is not a buy or sell recommendation ,, im here to share my ideas .
DOWN from Symmetrical Triangle I do not go short but this could go down a bit more. Symmetrical Triangle can break either way. This one broke to the downside
If bottom not formed here then next Possible target down may be 60.25
GILD: need to break the $67 barrierwe're still holding GILD and now it's making another attempt at recovering from the recent drop
we need to break the $67 and stay above it for couple of sessions - with strong volume - to flag a proper recovery - the prior attempt for a breakout failed - this time there's some momentum and demand - but still light.
we'll see
